NuVasive Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Brean Capital Raises Price Target on NuVasive (NUVA) to $70 Following Solid 2Q
July 27, 2016 11:04 AM EDTBrean Capital reiterated a Buy rating on NuVasive (NASDAQ: NUVA), and raised the price target to $70.00 (from $60.00), following the company's 2Q earnings report.
Analyst Jason Wittes commented, "NUVA reported a 16.4% (16.1% cc) revenue increase to $236.2 millionabove consensus and our $233.0 million estimate and was strong... More
NuVasive (NUVA) PT Raised to $72 at Jefferies
July 27, 2016 8:48 AM EDTJefferies analyst Raj Denhoy reiterated a Buy rating and lifted his price target on NuVasive (NASDAQ: NUVA) to $72.00 (from $63.00) following results.
Denhoy commented, "NuVasive put up a $2mn/$0.01 rev./EPS beat and raised guidance for the year. The top-line (+8.6% ex-FX, ex-NSO) was... More
NuVasive (NUVA) Tops Q2 EPS by 4c; Guides Abovce
July 26, 2016 4:05 PM EDTNuVasive (NASDAQ: NUVA) reported Q2 EPS of $0.40, $0.04 better than the analyst estimate of $0.36. Revenue for the quarter came in at $236.5 million versus the consensus estimate of $233.01 million.
GUIDANCE:
NuVasive sees FY2016 EPS of $1.64, versus the consensus of $1.51. NuVasive sees FY2016 revenue... More
